Iron Overload
📧 Sign up to get email alerts when something new happens for Iron Overload.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload [Phase 2]
A Phase 2 study evaluating an improved deferasirox granule formulation for treatment compliance, efficacy, and safety in pediatric patients …
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials
This completed clinical trial surveys physicians to evaluate their knowledge of Exjade dosing and biological monitoring as described in the …
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: MRI QSM Imaging for Iron Overload
The trial completed an evaluation of MRI quantitative susceptibility mapping (QSM) imaging as a noninvasive method to quantify iron overload…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children [Phase 4]
A Phase 4 trial evaluating safety and efficacy of early deferiprone treatment in infants and young children with beta-thalassemia major anem…
-
FDA approval · 2024-03-05FDA Approved: DEFERASIROX — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for deferasirox from Zydus Pharmaceuticals USA Inc., updating the product labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-02-05FDA Approved: DEFEROXAMINE MESYLATE — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental ANDA for deferoxamine mesylate submitted by Apotex Corp.
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias [Phase 4]
Phase 4 trial assessing long-term safety and efficacy of Ferriprox in iron-overloaded patients, including those with sickle cell disease and…
-
FDA approval · 2023-11-28FDA Approved: DEFEROXAMINE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Deferoxamine (deferoxamine mesylate) submitted by Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Long-term Clinical Study of CN128 in Thalassemia Patients [Phase 2]
Phase 2 long-term clinical study update for CN128 in thalassemia and iron overload conditions has completed.
-
FDA approval · 2023-11-14FDA Approved: DEFERASIROX — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for deferasirox submitted by Sun Pharmaceutical Industries, Inc., approving changes to the product l…
-
FDA approval · 2023-10-23FDA Approved: DEFEROXAMINE MESYLATE — Supplemental Application (Hospira, Inc.)
FDA approves a supplemental application for deferoxamine mesylate (Hospira) under ANDA076019.
-
FDA approval · 2023-10-16FDA Approved: DEFERASIROX — Original Application (NorthStar Rx LLC)
FDA approves NorthStar Rx LLC's original generic application for deferasirox, a once-daily oral iron chelator for reducing chronic iron over…
-
FDA approval · 2023-09-26FDA Approved: DEFERASIROX — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Deferasirox from Bionpharma Inc. under an ANDA, authorizing an additional regulatory action for …
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: Phlebotomy and Lifestyle and Diet Advices vs Lifestyle and Diet Advices Only in Patients With Dysmetabolic Liversiderosis [Phase 3]
Phase 3 trial comparing phlebotomy plus lifestyle and diet advice versus lifestyle and diet advice alone in patients with dysmetabolic liver…
-
FDA approval · 2023-04-28FDA Approved: DEFERASIROX ORAL GRANULES — Supplemental Application (EPIC PHARMA, LLC)
The FDA approved a supplemental application to authorize Deferasirox Oral Granules (DEFERASIROX) from Epic Pharma, LLC, for the treatment of…
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA) [Phase 2]
Phase 2 clinical trial evaluating ferrochelating treatment in patients with neurodegeneration with brain iron accumulation (NBIA).
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone [Phase 2]
Phase 2 clinical trial update on chelation therapy using Pyridoxal Isonicotinoyl Hydrazone for iron overload in anemia due to beta-thalassem…
-
FDA approval · 2022-09-09FDA Approved: DESFERAL — Supplemental Application (MITEM PHARMA)
The FDA approved a supplemental application for DESFERAL (deferoxamine mesylate) by MITEM PHARMA.
-
EMA approval · 2022-07-14EMA Authorised: Deferiprone Lipomed (Deferiprone) — Lipomed GmbH
EMA authorised Deferiprone Lipomed for iron overload and beta-thalassemia with Lipomed GmbH as marketing authorisation holder.
-
FDA approval · 2022-02-23FDA Approved: DEFERASIROX — Original Application (Cipla USA Inc.)
FDA approves a generic version of deferasirox (Cipla) under an original ANDA application.
-
FDA approval · 2022-02-11FDA Approved: JADENU — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for JADENU (deferasirox) submitted by Novartis Pharmaceuticals Corporation. The action updates the l…
-
FDA approval · 2021-11-30FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)
FDA approved a supplemental application for Ferriprox (deferiprone) submitted by Chiesi USA, Inc.
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients [Phase 2]
Phase 2 clinical trial evaluating deferasirox for treating transfusional iron overload in patients with myelodysplastic syndrome has complet…
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overload [Phase 2]
Phase 2 trial update on combined chelation therapy for transfusion-dependent thalassemia with iron overload; study completed with posted res…
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias [Phase 4]
Phase 4 clinical trial update on ferriprox for iron overload and sickle cell disease/other anemias; study terminated with results posted.